미국의 의료 코딩 시장 규모, 점유율 및 동향 분석 보고서 : 분류 시스템별, 구성 요소별, 의료 전문 분야별, 최종 용도별 및 부문별 예측(2026-2033년)

U.S. Medical Coding Market Summary

The U.S. medical coding market size was estimated at USD 21.6 billion in 2025 and is projected to reach USD 44.4 billion by 2033, growing at a CAGR of 9.6% from 2026 to 2033. Errors in billings, insurance fraud, and misinterpretations of medical documents result in large financial losses. Increasing losses due to ineffective medical billing and revenue cycle management are increasing demand for revenue cycle management including medical coding software and services. This, in turn, is estimated to drive market growth potential.

Market Drivers & Dynamics

The growing preference for outpatient healthcare delivery in the U.S. is significantly influencing the demand for medical coding services. Hospitals and health systems increasingly prioritize outpatient departments to manage rising patient volumes while improving operational efficiency. Moreover, ambulatory surgery centers (ASCs) significantly contribute to the growth of outpatient care in the U.S., providing same-day surgical procedures in specialties such as orthopedics, ophthalmology, gastroenterology, and pain management. With more than 6,000 centers nationwide performing over 20 million procedures annually, outsourcing of medical coding services is expected to rise over the forecast period.

Moreover, CMS continues to add procedures to the ASC-covered list, encouraging migration of surgical services away from inpatient hospital settings. For instance, in November 2025, CMC added 276 procedures to the ASC Covered Surgical Procedures and Ancillary Services Lists (CPL) and added an additional 271 codes to the ASC CPL.

In addition, the growing volume of healthcare administrative transactions in the U.S. is a significant driver of the medical coding market. For instance, according to the 2023 CAQH Index Report, the U.S. healthcare industry processed over 59 billion administrative transactions in 2023, including claims submissions, eligibility checks, claim status inquiries, and prior authorization requests. Among these, medical claims submission represents one of the most critical processes within healthcare revenue cycle management.

Furthermore, development of artificial intelligence (AI)-enabled medical coding is estimated to drive market growth. For instance, in April 2025, the Cleveland Clinic partnered with AKASA to deploy generative AI tools in mid-revenue-cycle operations across U.S. sites, automating medical coding from clinical documents. The AI processes 100+ documents in 1.5 minutes, boosting speed, accuracy, and prior authorizations while enhancing coder efficiency for complex cases.

Technology vendors across the country continue investing in advanced AI-driven medical coding platforms that integrate directly with electronic health record systems and revenue cycle management software. In August 2025, HGM Limited, through its U.S. subsidiary Healthcare Capital Holdings LLC (HCH), announced the acquisition of Aideo Technologies LLC, a leader in AI-powered autonomous coding solutions. This acquisition expands HGM's capabilities in revenue cycle management (RCM), medical coding, and healthcare analytics.

U.S. Medical Coding Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research, Inc. has segmented the U.S. medical coding market report based on classification system, component, medical specialty, and end use:

• Classification System Outlook (Revenue, USD Million, 2021 - 2033)
• ICD
• HCPCS
• CPT
• Component Outlook (Revenue, USD Million, 2021 - 2033)
• In-house
• Outsourced
  • Onshore
  • Offshore
• Medical Specialty Outlook (Revenue, USD Million, 2021 - 2033)
• Oncology
• Cardiology
• Anesthesia
• Radiology
• Pathology
• Pain Management
• Emergency Services
• Others
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Acute Care Hospitals
  • Inpatient Settings
  • Outpatient Settings
• Ambulatory Surgery Centers (ASC)

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
  • 1.2.1. Classification System Segment
  • 1.2.2. Component Segment
  • 1.2.3. Medical Specialty Segment
  • 1.2.4. End Use Segment
• 1.3. Information analysis
  • 1.3.1. Market formulation & data visualization
• 1.4. Data validation & publishing
• 1.5. Information Procurement
  • 1.5.1. Primary Research
• 1.6. Information or Data Analysis
• 1.7. Market Formulation & Validation
• 1.8. Market Model
• 1.9. Total Market: CAGR Calculation
• 1.10. Objectives
  • 1.10.1. Objective 1
  • 1.10.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Insights Landscape

Chapter 3. U.S. Medical Coding Market Variables, Trends, & Scope

• 3.1. Market Segmentation and Scope
• 3.2. Market Lineage Outlook
  • 3.2.1. Parent Market Outlook
  • 3.2.2. Related/Ancillary Market Outlook
• 3.3. Market Trends and Outlook
• 3.4. Market Driver Analysis
• 3.5. Market Restraint Analysis
• 3.6. Business Environment Analysis
  • 3.6.1. PESTLE Analysis
  • 3.6.2. Porter's Five Forces Analysis
• 3.7. Case Study Insights

Chapter 4. U.S. Medical Coding Market: Classification System Estimates & Trend Analysis

• 4.1. U.S. Medical Coding Market: Classification System Movement and Market Share Analysis
• 4.2. U.S. Medical Coding Classification System Market: Segment Dashboard
• 4.3. ICD
  • 4.3.1. ICD Market, 2021 - 2033 (USD Million)
• 4.4. CPT
  • 4.4.1. CPT Market, 2021 - 2033 (USD Million)
• 4.5. HCPCS
  • 4.5.1. HCPCS Market, 2021 - 2033 (USD Million)

Chapter 5. U.S. Medical Coding Market: Component Estimates & Trend Analysis

• 5.1. U.S. Medical Coding Market: Component Movement and Market Share Analysis
• 5.2. U.S. Medical Coding Component Market: Segment Dashboard
• 5.3. In-house
  • 5.3.1. In-house Market, 2021 - 2033 (USD Million)
• 5.4. Outsourced
  • 5.4.1. Outsourced Market, 2021 - 2033 (USD Million)
  • 5.4.2. Onshore
    • 5.4.2.1. Onshore Market, 2021 - 2033 (USD Million)
  • 5.4.3. Offshore
    • 5.4.3.1. Offshore Market, 2021 - 2033 (USD Million)

Chapter 6. U.S. Medical Coding Market: Medical Specialty Estimates & Trend Analysis

• 6.1. U.S. Medical Coding Market: Medical Specialty Movement and Market Share Analysis
• 6.2. U.S. Medical Coding Medical Specialty Market: Segment Dashboard
• 6.3. Oncology
  • 6.3.1. Oncology Market, 2021 - 2033 (USD Million)
• 6.4. Cardiology
  • 6.4.1. Cardiology Market, 2021 - 2033 (USD Million)
• 6.5. Anesthesia
  • 6.5.1. Anesthesia Market, 2021 - 2033 (USD Million)
• 6.6. Radiology
  • 6.6.1. Radiology Market, 2021 - 2033 (USD Million)
• 6.7. Pain Management
  • 6.7.1. Pain Management Market, 2021 - 2033 (USD Million)
• 6.8. Pathology
  • 6.8.1. Pathology Market, 2021 - 2033 (USD Million)
• 6.9. Emergency Services
  • 6.9.1. Emergency Services Market, 2021 - 2033 (USD Million)
• 6.10. Others
  • 6.10.1. Others Market, 2021 - 2033 (USD Million)

Chapter 7. U.S. Medical Coding Market: Services Estimates & Trend Analysis

• 7.1. U.S. Medical Coding Market: Component Movement and Market Share Analysis
• 7.2. U.S. Medical Coding Component Market: Segment Dashboard
• 7.3. Acute Care Hospitals
  • 7.3.1. Acute Care Hospitals Market, 2021 - 2033 (USD Million)
  • 7.3.2. Inpatient Settings
    • 7.3.2.1. Inpatient Settings Market, 2021 - 2033 (USD Million)
  • 7.3.3. Outpatient Settings
    • 7.3.3.1. Outpatient Settings Market, 2021 - 2033 (USD Million)
• 7.4. Ambulatory Surgery Centers (ASC)
  • 7.4.1. Ambulatory Surgery Centers (ASC) Market, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Participant's Overview
• 8.2. Financial Performance
• 8.3. Company Market Position Analysis
• 8.4. Strategy Mapping
  • 8.4.1. Expansion
  • 8.4.2. Acquisition
  • 8.4.3. Collaborations
  • 8.4.4. New Product Launches
  • 8.4.5. Partnerships
  • 8.4.6. Others
• 8.5. Participant's overview
  • 8.5.1. Oracle
    • 8.5.1.1. Overview
    • 8.5.1.2. Financial Performance
    • 8.5.1.3. Product Benchmarking
    • 8.5.1.4. Strategic Initiatives
  • 8.5.2. Maxim Healthcare Services (Amergis)
    • 8.5.2.1. Overview
    • 8.5.2.2. Financial Performance
    • 8.5.2.3. Product Benchmarking
    • 8.5.2.4. Strategic Initiatives
  • 8.5.3. Datavant
    • 8.5.3.1. Overview
    • 8.5.3.2. Financial Performance
    • 8.5.3.3. Product Benchmarking
    • 8.5.3.4. Strategic Initiatives
  • 8.5.4. Aviacode Inc. (GeBBS)
    • 8.5.4.1. Overview
    • 8.5.4.2. Financial Performance
    • 8.5.4.3. Product Benchmarking
    • 8.5.4.4. Strategic Initiatives
  • 8.5.5. Precyse Solutions, LLC
    • 8.5.5.1. Overview
    • 8.5.5.2. Financial Performance
    • 8.5.5.3. Product Benchmarking
    • 8.5.5.4. Strategic Initiatives
  • 8.5.6. Verisk Analytics, Inc.
    • 8.5.6.1. Overview
    • 8.5.6.2. Financial Performance
    • 8.5.6.3. Product Benchmarking
    • 8.5.6.4. Strategic Initiatives
  • 8.5.7. Omega Healthcare Management Services
    • 8.5.7.1. Overview
    • 8.5.7.2. Financial Performance
    • 8.5.7.3. Product Benchmarking
    • 8.5.7.4. Strategic Initiatives
  • 8.5.8. PrimEra Medical Technologies
    • 8.5.8.1. Overview
    • 8.5.8.2. Financial Performance
    • 8.5.8.3. Product Benchmarking
    • 8.5.8.4. Strategic Initiatives
  • 8.5.9. Dolbey
    • 8.5.9.1. Overview
    • 8.5.9.2. Financial Performance
    • 8.5.9.3. Product Benchmarking
    • 8.5.9.4. Strategic Initiatives
  • 8.5.10. 20/20 MD
    • 8.5.10.1. Overview
    • 8.5.10.2. Financial Performance
    • 8.5.10.3. Product Benchmarking
    • 8.5.10.4. Strategic Initiatives